Ischemic Stroke Clinical Trial
Official title:
Changes in Motor Function and Functional Brain Connectivity on Subacute Ischemic Stroke Patients, Associated With a New Videogame Therapy Platform
NCT number | NCT05283369 |
Other study ID # | 127/21 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | December 2, 2022 |
Est. completion date | November 2025 |
The use of interactive applications associated with movement sensors has begun to spread as an option for the reinforcement of physical rehabilitation therapies in patients with acquired motor disabilities as a consequence of some neurological damage, due to their portability and the relative autonomy that they grant to the patient. However, the results of its effectiveness and impact continue to be discreet compared to traditional therapy. The present study aims to explore possible changes in motor function and in the brain's functional connectivity through resting-state functional Magnetic Resonance Imaging (rs-fMRI), for subacute ischemic stroke outpatients, associated with occupational therapy using interactive applications as a therapeutic complement, comparing with patients on conventional therapy, for which a randomized pilot study with an experimental group and a matched control group will be carried out. The intervention will consist of the application of a virtual rehabilitation program in addition to physical therapy for the experimental group, while the control group will receive conventional physical therapy. Before and after the said intervention, standardized tests will be applied to evaluate the mobility, motor function, and cognitive impairment of the participants. The results obtained will be subject to statistical analysis.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | November 2025 |
Est. primary completion date | November 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - Upper extremity hemiparesis caused by ischemic stroke on its dominant side or not - In the subacute phase. From 2 to 16 weeks of ischemic stroke event - Fugl-Meyer Upper Extremity > 15 - No previous stroke Exclusion Criteria: - Token Test < 17. Inability to understand verbal instructions - Instability of the shoulder, elbow, or wrist joints - Severe concomitant medical problems such as congestive heart failure or seizures - Anosognosia - Severe aphasia - Hemispatial neglect - Visual impairments that are not corrected with glasses - Uncompensated hearing impairment - Patients receiving concomitant therapies |
Country | Name | City | State |
---|---|---|---|
Mexico | Ana María Escalante-Gonzalbo | Mexico City | Tlalpan, CDMX |
Lead Sponsor | Collaborator |
---|---|
Universidad Nacional Autonoma de Mexico | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez |
Mexico,
Escalante-Gonzalbo AM, Ramirez-Graullera YS, Pasantes H, Aguilar-Chale JJ, Sanchez-Castillo GI, Escutia-Macedo XA, Briseno-Soriano TM, Franco-Castro P, Estrada-Rosales AL, Vazquez-Abundes SE, Andrade-Morales D, Hernandez-Franco J, Palafox L. Safety, Feasi — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Changes in brain functional connectivity, measured by fMRI | Changes in brain functional connectivity, measured by fMRI | Baseline, 8 Weeks | |
Primary | Fugl-Meyer Upper Extremity Test (FMUE) | The Fugl-Meyer test for Upper extremity. To assess level of motor disability | Baseline, 8 Weeks | |
Secondary | Wolf Motor Function Test (WMFT) | The Wolf Motor Function Test. To assess motor skill level | Baseline, 8 Weeks | |
Secondary | Chedoke Arm and Hand Activity Inventory (CAHAI-7) | The Chedoke Arm and Hand Activity Inventory 7 tasks Test. To assess motor function | Baseline, 8 Weeks | |
Secondary | Barthel Index | The Barthel Index. To assess the level of independence in carrying out activities of daily living | Baseline, 8 Weeks | |
Secondary | Trail Making Test (TMT) | A digital implementation of the Trail Making Test. To assess Changes in cognitive function in terms of speed of executive functions and attention | Baseline, 8 Weeks | |
Secondary | Corsi block-tapping test | A digital implementation of the Corsi block-tapping test. To assess changes in working memory | Baseline, 8 Weeks | |
Secondary | WAIS IV - Perceptual Reasoning section (PRI) | Perceptual Reasoning Section of the Wechsler Adult Intelligence Scale (WAIS-IV) | Baseline, 8 Weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A |